Endpoints News 5. Dez. 2025 Denali drug hold; Intercept layoffs; Capital raises for Immatics, Capricor and Protara
Endpoints News 5. Dez. 2025 OTR Therapeutics gets $100M from Pfizer Ventures, others to build asset portfolio
Endpoints News 5. Dez. 2025 German court stops Merck from selling subcutaneous Keytruda in patent battle with Halozyme
Endpoints News 5. Dez. 2025 Ex-Intercept CEO takes over at Altimmune; Carolyn Bertozzi leaves Alnylam's board
Endpoints News 4. Dez. 2025 Prasad's claim of 10 Covid vaccine deaths may be an overcount: FDA sources
Endpoints News 4. Dez. 2025 Trump administration pushes end-of-term deadline for ‘most favored nation’ promises
Endpoints News 4. Dez. 2025 UniQure restates FDA's negative feedback on Huntington's trial; Neurimmune's expanded AstraZeneca alliance
Endpoints News 4. Dez. 2025 BioNexus gets $500M to step into manufacturing; Thermo Fisher, AtomVie expand